Effects of glucocorticoids on fetal and neonatal lung development

Area of Science:

• * Perinatal Medicine
• * Developmental Biology
• * Respiratory Physiology

Background:

• * Antenatal glucocorticoids are widely used to promote fetal lung maturation in preterm infants.
• * Their primary recognized effect is stimulating the pulmonary surfactant system.
• * Emerging evidence indicates broader impacts on lung gene expression and development.

Purpose of the Study:

• * To explore the multifaceted effects of antenatal glucocorticoids on fetal lung development.
• * To identify specific genes and pathways influenced by these corticosteroids.
• * To understand the mechanisms underlying both beneficial and potentially detrimental effects on lung structure and function.

Main Methods:

• * Review of existing literature on glucocorticoid effects on fetal lung development.
• * Analysis of gene expression changes induced by glucocorticoids.
• * Examination of impacts on surfactant production, antioxidant enzymes, fluid transport, and alveolarization.

Main Results:

• * Glucocorticoids upregulate genes for surfactant proteins, fatty acid synthase, sodium/potassium ATPase, and antioxidant enzymes (catalase, glutathione peroxidase, superoxide dismutases).
• * They also increase vascular endothelial growth factor, potentially inhibiting alveolarization and causing enlarged alveoli.
• * Effects extend to lung fluid absorption and overall alveolar development.

Conclusions:

• * Antenatal glucocorticoids exert complex effects on fetal lung maturation beyond surfactant production.
• * Understanding these diverse mechanisms is crucial for managing respiratory distress syndrome.
• * Further research is needed to develop targeted therapies and mitigate potential long-term adverse effects.